Literature DB >> 1498341

Antipyrine as a dialyzable reference to correct differences in efficiency among and within sampling devices during in vivo microdialysis.

R A Yokel1, D D Allen, D E Burgio, P J McNamara.   

Abstract

Antipyrine was investigated as a dialyzable substance that could be used to quantitate relative differences in the efficiency of dialysis among multiple microdialysis probes and by a single probe over time. The contribution of effective membrane surface area to recovery variability was tested by the introduction of air into microdialysis probes. Reduction of effective membrane surface area reduced antipyrine recovery. Dialysates from probes implanted in the jugular vein, brain, and liver of rats receiving antipyrine demonstrated differences in antipyrine concentration among probes within the same rat. These results suggest dissimilar efficiencies of the probes to recover antipyrine, which should be uniformly distributed throughout body water. Dialysates from blood, brain, and liver probes in rats that received both antipyrine and tritiated water (3H2O) showed differences in antipyrine and 3H2O concentrations among probes. Variability of antipyrine and 3H2O concentrations over time within a probe were positively correlated, suggesting that the cause(s) of temporal variability affected both of these markers of body water. Correction of antipyrine tissue/blood ratios, using 3H2O blood/tissue ratios from the same sampling period, reduced the variability in antipyrine tissue/blood ratios, producing ratios closer to the expected value of 1. Differences in probe efficiency contributing to the variability of antipyrine and 3H2O recovery would also be expected to influence the recovery of other substances during microdialysis. The administration of antipyrine during microdialysis experiments is suggested to enable reduction of temporal and site-related differences in substance recovery that are due to differences in probe efficiency. Other methods are necessary to determine the actual extracellular concentration of dialyzed substances and the integrity of the blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1498341     DOI: 10.1016/1056-8719(92)90034-x

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  12 in total

1.  Development of tissue-targeted metabonomics. Part 1. Analytical considerations.

Authors:  Kristin E Price; Craig E Lunte; Cynthia K Larive
Journal:  J Pharm Biomed Anal       Date:  2007-11-29       Impact factor: 3.935

Review 2.  Application of microdialysis in pharmacokinetic studies.

Authors:  W F Elmquist; R J Sawchuk
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

Review 3.  Pharmacokinetic and metabolism studies using microdialysis sampling.

Authors:  D K Hansen; M I Davies; S M Lunte; C E Lunte
Journal:  J Pharm Sci       Date:  1999-01       Impact factor: 3.534

Review 4.  A Review on Microdialysis Calibration Methods: the Theory and Current Related Efforts.

Authors:  Chun Min Kho; Siti Kartini Enche Ab Rahim; Zainal Arifin Ahmad; Norazharuddin Shah Abdullah
Journal:  Mol Neurobiol       Date:  2016-05-17       Impact factor: 5.590

5.  Fluconazole distribution to the brain: a crossover study in freely-moving rats using in vivo microdialysis.

Authors:  H Yang; Q Wang; W F Elmquist
Journal:  Pharm Res       Date:  1996-10       Impact factor: 4.200

6.  The use of microdialysis for the study of drug kinetics: some methodological considerations illustrated with antipyrine in rat frontal cortex.

Authors:  P N Patsalos; W T Abed; M S Alavijeh; M T O'Connell
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

7.  Long-term calibration considerations during subcutaneous microdialysis sampling in mobile rats.

Authors:  Xiaodun Mou; Michelle R Lennartz; Daniel J Loegering; Julie A Stenken
Journal:  Biomaterials       Date:  2010-03-11       Impact factor: 12.479

Review 8.  In vivo microdialysis for PK and PD studies of anticancer drugs.

Authors:  Qingyu Zhou; James M Gallo
Journal:  AAPS J       Date:  2005-10-24       Impact factor: 4.009

9.  The design and validation of a novel intravenous microdialysis probe: application to fluconazole pharmacokinetics in the freely-moving rat model.

Authors:  H Yang; Q Wang; W F Elmquist
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

10.  Microdialysis calibration using retrodialysis and zero-net flux: application to a study of the distribution of zidovudine to rabbit cerebrospinal fluid and thalamus.

Authors:  Y Wang; S L Wong; R J Sawchuk
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.